Standard
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors : a systematic review and individual participant data meta-analysis. / Siskind, Dan; Hahn, Margaret; Correll, Christoph U.; Fink-Jensen, Anders; Russell, Anthony W.; Bak, Nikolaj; Broberg, Brian V.; Larsen, Julie; Ishoy, Pelle L.; Vilsbøll, Tina; Knop, Filip K.; Kisely, Steve; Ebdrup, Bjorn H.
I:
Diabetes, Obesity and Metabolism, Bind 21, Nr. 2, 2019, s. 293-302.
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
Siskind, D, Hahn, M, Correll, CU
, Fink-Jensen, A, Russell, AW, Bak, N, Broberg, BV, Larsen, J, Ishoy, PL
, Vilsbøll, T, Knop, FK, Kisely, S
& Ebdrup, BH 2019, '
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis',
Diabetes, Obesity and Metabolism, bind 21, nr. 2, s. 293-302.
https://doi.org/10.1111/dom.13522APA
Siskind, D., Hahn, M., Correll, C. U.
, Fink-Jensen, A., Russell, A. W., Bak, N., Broberg, B. V., Larsen, J., Ishoy, P. L.
, Vilsbøll, T., Knop, F. K., Kisely, S.
, & Ebdrup, B. H. (2019).
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis.
Diabetes, Obesity and Metabolism,
21(2), 293-302.
https://doi.org/10.1111/dom.13522Vancouver
Siskind D, Hahn M, Correll CU
, Fink-Jensen A, Russell AW, Bak N o.a.
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis.
Diabetes, Obesity and Metabolism. 2019;21(2):293-302.
https://doi.org/10.1111/dom.13522Author
Siskind, Dan ; Hahn, Margaret ; Correll, Christoph U. ; Fink-Jensen, Anders ; Russell, Anthony W. ; Bak, Nikolaj ; Broberg, Brian V. ; Larsen, Julie ; Ishoy, Pelle L. ; Vilsbøll, Tina ; Knop, Filip K. ; Kisely, Steve ; Ebdrup, Bjorn H. / Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors : a systematic review and individual participant data meta-analysis. I: Diabetes, Obesity and Metabolism. 2019 ; Bind 21, Nr. 2. s. 293-302.
Bibtex
@article{88e5a0b56ba443b3b3c791ed97dc0b78,
title = "Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis",
keywords = "antipsychotics, body weight loss, cardiovascular risk, GLP-1RAs, obesity, schizophrenia",
author = "Dan Siskind and Margaret Hahn and Correll, {Christoph U.} and Anders Fink-Jensen and Russell, {Anthony W.} and Nikolaj Bak and Broberg, {Brian V.} and Julie Larsen and Ishoy, {Pelle L.} and Tina Vilsb{\o}ll and Knop, {Filip K.} and Steve Kisely and Ebdrup, {Bjorn H.}",
year = "2019",
doi = "10.1111/dom.13522",
language = "English",
volume = "21",
pages = "293--302",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "2",
}
RIS
TY - JOUR
T1 - Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors
T2 - a systematic review and individual participant data meta-analysis
AU - Siskind, Dan
AU - Hahn, Margaret
AU - Correll, Christoph U.
AU - Fink-Jensen, Anders
AU - Russell, Anthony W.
AU - Bak, Nikolaj
AU - Broberg, Brian V.
AU - Larsen, Julie
AU - Ishoy, Pelle L.
AU - Vilsbøll, Tina
AU - Knop, Filip K.
AU - Kisely, Steve
AU - Ebdrup, Bjorn H.
PY - 2019
Y1 - 2019
KW - antipsychotics
KW - body weight loss
KW - cardiovascular risk
KW - GLP-1RAs
KW - obesity
KW - schizophrenia
U2 - 10.1111/dom.13522
DO - 10.1111/dom.13522
M3 - Review
C2 - 30187620
VL - 21
SP - 293
EP - 302
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 2
ER -
